HCA Healthcare EVP & Chief Clinical Officer Files Initial Beneficial Ownership (Form 3)

HCA Healthcare, Inc. ($HCA) – Initial Statement of Beneficial Ownership (Form 3)

Overview

On September 11, 2026, Michael J. Schlosser, Executive Vice President and Chief Clinical Officer of HCA Healthcare, Inc., filed an initial Form 3 reflecting his beneficial ownership position as of September 1, 2026.

---

Summary of Reported Holdings

1. Non-Derivative Securities (Common Stock)

• Direct Ownership: 170.1027 shares of Common Stock (acquired through the Issuer's employee stock purchase plan).
• Indirect Ownership: 6,951 shares of Common Stock held via the 2022 Trust.
• Total Common Stock Beneficial Ownership: 7,121.1027 shares.

2. Derivative Securities (Stock Appreciation Rights - SARs)

Dr. Schlosser holds 12 tranches of Stock Appreciation Rights covering 38,152 underlying shares of Common Stock at exercise prices ranging from $81.96 to $482.53:

• $81.96 SARs: 3,030 shares (Exp: 2027-02-01)
• $82.85 SARs: 1,898 shares (Exp: 2027-05-03)
• $101.16 SARs: 6,290 shares (Exp: 2028-01-31)
• $139.06 SARs: 4,400 shares (Exp: 2029-01-30)
• $145.24 SARs: 2,420 shares (Exp: 2030-01-29)
• $173.12 SARs: 2,100 shares (Exp: 2031-02-03)
• $246.79 SARs: 2,370 shares (Exp: 2031-07-22)
• $236.61 SARs: 4,160 shares (Exp: 2032-01-28)
• $253.30 SARs: 3,789 shares (Exp: 2033-01-30)
• $304.90 SARs: 3,577 shares (Exp: 2034-01-31)
• $328.70 SARs: 3,575 shares (Exp: 2035-01-28)
• $482.53 SARs: 3,103 shares (Exp: 2036-01-29)

---

Market & Trading Significance

• Significance Level: Low.
• Form 3 is an administrative baseline filing disclosing existing equity stakes upon becoming a designated Section 16 insider. It involves no open-market buying or selling activity.